Overview

Lybra Bio is reshaping the treatment landscape of Autoimmune Skin Diseases. They are developing innovative therapeutics platforms aiming to restore the skin’s immune equilibrium in patients suffering from Autoimmune Skin Diseases. Lybra Bio’s first platform combines clinically validated cytokines loaded into an advanced microneedle patch for superior efficacy and patient compliance while bypassing systemic side effects.